[HTML][HTML] Toxin-like peptides from the bacterial cultures derived from gut microbiome infected by SARS-CoV-2—new data for a possible role in the long COVID pattern

C Brogna, S Cristoni, B Brogna, DR Bisaccia, G Marino… - Biomedicines, 2022 - mdpi.com
It has been 3 years since the beginning of the SARS-CoV-2 outbreak, however it is as yet
little known how to care for the acute COVID-19 and long COVID patients. COVID-19 clinical …

A lesson from a saboteur: High‐MW kininogen impact in coronavirus‐induced disease 2019

C Colarusso, M Terlizzi, A Pinto… - British Journal of …, 2020 - Wiley Online Library
The newly identified coronavirus SARS‐CoV‐2 that spread from China is causing the
pandemic COVID‐19 with a fatality rate from 5‐15%. It causes fever, cough, myalgia, fatigue …

Angioedema in COVID-19

AJ Cohen, MF DiFrancesco, SD Solomon… - European Heart …, 2020 - academic.oup.com
A 62-year-old man with a history of hypertension presented with 12 h of lip and facial
swelling. Twelve days prior to presentation, he developed fevers (up to 39 C), chills, fatigue …

What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?

LAD Nicolau, PJC Magalhães, ML Vale - Medical hypotheses, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease with fast spreading
all over the world caused by the SARS-CoV-2 virus which can culminate in a severe acute …

[HTML][HTML] The role of Substance P in the defense line of the respiratory tract and neurological manifestations post COVID-19 infection

R Mehboob, P Oehme, G Pfaff - Frontiers in Neurology, 2023 - frontiersin.org
Substance P (SP) has been a great interest for scientists due to its unique properties and
involvement in various physiological and pathological phenomenon. It took almost a century …

[HTML][HTML] Therapeutic polypeptides and peptidomimetics: powerful tools for COVID-19 treatment

X Liu, J Shi, D Wang, Y Su, Z Xing, F Sun… - Clinical Drug …, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has swept the whole world
and brought about a public health crisis of unprecedented proportions. To combat the rapid …

[HTML][HTML] Pathways for bradykinin formation and interrelationship with complement as a cause of edematous lung in COVID-19 patients

AP Kaplan, B Ghebrehiwet - The Journal of allergy and clinical …, 2021 - ncbi.nlm.nih.gov
The beta coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infects lung alveolar type II epithelial calls by attaching to angiotensin-converting enzyme 2 …

[HTML][HTML] Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy

LCG Oliveira, NAN Cruz, B Ricelli… - Journal of Venomous …, 2021 - SciELO Brasil
Abstract Coronavirus disease 2019 (COVID-19) is a rapid-spread infectious disease caused
by the SARS-CoV-2 virus, which can culminate in the renin-angiotensin-aldosterone (RAAS) …

[HTML][HTML] The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites

K Hüfner, S Vedova, P Tymoszuk, P Nelles… - …, 2023 - Elsevier
Background A high prevalence of mental disorders following COVID-19 has been described.
It is therefore essential to elucidate underlying biological mechanisms linking SARS-CoV-2 …

The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology

D Sohaei, M Hollenberg, SJ Janket… - Critical Reviews in …, 2023 - Taylor & Francis
Abstract While coronavirus disease 2019 (COVID-19) begins as a respiratory infection, it
progresses as a systemic disease involving multiorgan microthromboses that underly the …